Thermo Fisher Scientific Inc. TN8.F Stock
Thermo Fisher Scientific Inc. Price Chart
Thermo Fisher Scientific Inc. TN8.F Financial and Trading Overview
Thermo Fisher Scientific Inc. stock price | 523.4 EUR |
Previous Close | 457.3 EUR |
Open | 460.4 EUR |
Bid | 462 EUR x 60000 |
Ask | 465 EUR x 60000 |
Day's Range | 460.4 - 460.4 EUR |
52 Week Range | 398 - 556 EUR |
Volume | 43 EUR |
Avg. Volume | 59 EUR |
Market Cap | 179.72B EUR |
Beta (5Y Monthly) | 0.827 |
PE Ratio (TTM) | 32.468266 |
EPS (TTM) | 14.34 EUR |
Forward Dividend & Yield | 1.31 (0.28%) |
Ex-Dividend Date | December 14, 2023 |
1y Target Est | N/A |
TN8.F Valuation Measures
Enterprise Value | 206.11B EUR |
Trailing P/E | 32.468266 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.1391153 |
Price/Book (mrq) | 3.9244099 |
Enterprise Value/Revenue | 4.747 |
Enterprise Value/EBITDA | 19.012 |
Trading Information
Thermo Fisher Scientific Inc. Stock Price History
Beta (5Y Monthly) | 0.827 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 556 EUR |
52 Week Low | 398 EUR |
50-Day Moving Average | 441.99 EUR |
200-Day Moving Average | 482.71 EUR |
TN8.F Share Statistics
Avg. Volume (3 month) | 59 EUR |
Avg. Daily Volume (10-Days) | 38 EUR |
Shares Outstanding | 386.37M |
Float | 385.68M |
Short Ratio | N/A |
% Held by Insiders | 0.17% |
% Held by Institutions | 91.21% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.35 |
Trailing Annual Dividend Yield | 0.29% |
5 Year Average Dividend Yield | 22.00% |
Payout Ratio | 0.0885 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.68% |
Operating Margin (ttm) | 18.43% |
Gross Margin | 39.95% |
EBITDA Margin | 24.96% |
Management Effectiveness
Return on Assets (ttm) | 4.94% |
Return on Equity (ttm) | 13.28% |
Income Statement
Revenue (ttm) | 43.42B EUR |
Revenue Per Share (ttm) | 112.05 EUR |
Quarterly Revenue Growth (yoy) | -1.00000000000000000000000000000000% |
Gross Profit (ttm) | 19B EUR |
EBITDA | 10.84B EUR |
Net Income Avi to Common (ttm) | 5.94B EUR |
Diluted EPS (ttm) | 14.18 |
Quarterly Earnings Growth (yoy) | 14.69% |
Balance Sheet
Total Cash (mrq) | 6.15B EUR |
Total Cash Per Share (mrq) | 15.92 EUR |
Total Debt (mrq) | 35.44B EUR |
Total Debt/Equity (mrq) | 77.94 EUR |
Current Ratio (mrq) | 1.631 |
Book Value Per Share (mrq) | 117.317 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.17B EUR |
Levered Free Cash Flow (ttm) | 4.63B EUR |
Profile of Thermo Fisher Scientific Inc.
Country | Germany |
State | MA |
City | Waltham |
Address | 168 Third Avenue |
ZIP | 02451 |
Phone | 781 622 1000 |
Website | https://www.thermofisher.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 130000 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Q&A For Thermo Fisher Scientific Inc. Stock
What is a current TN8.F stock price?
Thermo Fisher Scientific Inc. TN8.F stock price today per share is 523.4 EUR.
How to purchase Thermo Fisher Scientific Inc. stock?
You can buy TN8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Thermo Fisher Scientific Inc.?
The stock symbol or ticker of Thermo Fisher Scientific Inc. is TN8.F.
Which industry does the Thermo Fisher Scientific Inc. company belong to?
The Thermo Fisher Scientific Inc. industry is Diagnostics & Research.
How many shares does Thermo Fisher Scientific Inc. have in circulation?
The max supply of Thermo Fisher Scientific Inc. shares is 383M.
What is Thermo Fisher Scientific Inc. Price to Earnings Ratio (PE Ratio)?
Thermo Fisher Scientific Inc. PE Ratio is 36.49930600 now.
What was Thermo Fisher Scientific Inc. earnings per share over the trailing 12 months (TTM)?
Thermo Fisher Scientific Inc. EPS is 14.34 EUR over the trailing 12 months.
Which sector does the Thermo Fisher Scientific Inc. company belong to?
The Thermo Fisher Scientific Inc. sector is Healthcare.